American Journal of Cardiology
Volume 101, Issue 9 , Pages 1232-1238 , 1 May 2008

Relation of Hyperemic Epicardial Flow to Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy

  • C. Michael Gibson, MS, MD

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617-278-0145; fax: 617-734-7329.
    • ,
  • Yuri B. Pride, MD

      Affiliations

    • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Jacqueline L. Buros, BA

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Vijayalakshmi Kunadian, MBBS, MD, MRCP

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Matthew C. Southard, BS

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Caitlin J. Harrigan, BA

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Lauren N. Ciaglo, BA

      Affiliations

    • TIMI Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Marc S. Sabatine, MD, MPH

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
    • ,
  • Christopher P. Cannon, MD

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
    • ,
  • Eugene Braunwald, MD

      Affiliations

    • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Received 12 August 2007 ,Revised 27 December 2007 ,Accepted 27 December 2007.

References 

  1. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial (Phase I findings). N Engl J Med. 1985;312:932–936
  2. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615–1622
  3. Ellis SG, da Silva ER, Heyndrickx G, Talley JD, Cernigliaro C, Steg G, et al Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 1994;90:2280–2284
  4. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–888
  5. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–1913
  6. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis In Myocardial Infarction trials. J Am Coll Cardiol. 2003;42:7–16
  7. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 1990;82:781–791
  8. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol. 1999;34:1954–1962
  9. Ross AM, Lundergan CF, Rohrbeck SC, Boyle DH, van den Brand M, Buller CH, et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. J Am Coll Cardiol. 1998;31:1511–1517
  10. Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol. 2001;88:831–836
  11. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol. 1993;21:1391–1395
  12. Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99:1945–1950
  13. Gould KL. Coronary Artery Stenosis. New York, New York: Elsevier; 1991;
  14. Dorge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol. 2000;279:H2587–H2592
  15. Herzberg RM, Rubio R, Berne RM. Coronary occlusion and embolization: effect on blood flow in adjacent arteries. Am J Physiol. 1966;210:169–175
  16. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 1986;250:H509–H518
  17. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179–1189
  18. Sabatine MS, McCabe CH, Gibson CM, Cannon CP. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis In Myocardial Infarction (CLARITY-TIMI) 28 trial. Am Heart J. 2005;149:227–233
  19. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130
  20. Braunwald E, Zipes DP, Libby P. Heart Disease. New York, New York: W.B. Saunders; 2001;
  21. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989;32:73–97
  22. Brown IP, Thompson CI, Belloni FL. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart. Am J Physiol. 1993;264:H821–H829
  23. Duffy SJ, Castle SF, Harper RW, Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation. 1999;100:1951–1957
  24. Skyschally A, Schulz R, Erbel R, Heusch G. Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol. 2002;282:H611–H614
  25. Gibson CM, Morrow DA, Murphy SA, Palabrica TM, Jennings LK, Stone PH, et al A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006;47:2364–2373
  26. Jorgensen L, Rowsell HC, Hovig T, Glynn MF, Mustard JF. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest. 1967;17:616–644
  27. Leach IH, Blundell JW, Rowley JM, Turner DR. Acute ischaemic lesions in death due to ischaemic heart disease (An autopsy study of 333 cases of out-of-hospital death). Eur Heart J. 1995;16:1181–1185
  28. Prati F, Pawlowski T, Gil R, Labellarte A, Gziut A, Caradonna E, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? (A serial intravascular ultrasound study). Circulation. 2003;107:2320–2325
  29. Erbel R, Heusch G. Coronary microembolization—its role in acute coronary syndromes and interventions. Herz. 1999;24:558–575
  30. Cavallini C, Savonitto S, Violini R, Arraiz G, Plebani M, Olivari Z, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J. 2005;26:1494–1498

 This study was supported in part by a grant from Sanofi-Aventis, Paris, France, and Bristol-Myers Squibb, Princeton, New Jersey.

PII: S0002-9149(08)00047-7

doi: 10.1016/j.amjcard.2007.12.023

American Journal of Cardiology
Volume 101, Issue 9 , Pages 1232-1238 , 1 May 2008

Article Tools

* Image Usage & Resolution